Pharmacokinetics, Pharmacodynamics and Tolerability of Opicapone, a Novel Catechol-O-Methyltransferase Inhibitor, in Healthy Subjects

Crystal structure of catechol O-methyltransferase

Jukka Vidgren, L.A. Svensson, Anders Liljas · Nature · 1994 · 438 citations

Life Sciences, Biochemistry, Chemistry +11

Management of Parkinson's disease: An evidence-based review

Anthony E. Lang, Andrew J. Lees · Movement Disorders · 2002 · 183 citations

Medicine, Neurology, Neuroscience +12

Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-<i>O</i>-methyltransferase

László E. Kiss, Humberto Ferreira, Leonel Torrão et al. · Journal of Medicinal Chemistry · 2010 · 167 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier

Lester A. Wade, Robert Katzman · Life Sciences · 1975 · 140 citations

Medicine, Neuroscience, Pharmacology +14

Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone

T. Ker�nen, A. Gordin, MariAnne Karlsson et al. · European Journal of Clinical Pharmacology · 1994 · 126 citations

Medicine, Pharmacokinetics, Pharmacology +8